Open AccessAbstract 3398: PTPN22 is a systemic target for augmenting antitumor immunity
Author(s) -
Won Jin Ho,
Lin Jiao,
Ludmila Danilova,
Zaw Phyo,
Soren Charmsaz,
Aditya Mohan,
Todd D. Armstrong,
Ben Ho Park,
Elana J. Fertig,
Zhong-Yin Zhang,
Elizabeth M. Jaffee
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-3398
Subject(s) - ptpn22 , biology , cd8 , cancer research , zap70 , granzyme b , immune system , cancer immunotherapy , cytotoxic t cell , t cell receptor , immunotherapy , cancer immunology , immunology , protein tyrosine phosphatase , t cell , immune checkpoint , microbiology and biotechnology , signal transduction , in vitro , biochemistry , gene , genotype , single nucleotide polymorphism